Toggle Main Menu Toggle Search

Open Access padlockePrints

Mosaic caveolin-3 expression in acquired rippling muscle disease without evidence of myasthenia gravis or acetylcholine receptor autoantibodies

Lookup NU author(s): Dr Rita Barresi, Professor Giorgio TascaORCiD, Professor Volker StraubORCiD

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


Abstract

Inherited rippling muscle disease is an autosomal dominant disorder usually associated with caveolin-3 mutations. Rare cases of acquired rippling muscle disease with abnormal caveolin-3 localisation have been reported, without primary caveolin-3 mutations and in association with myasthenia gravis and acetylcholine receptor autoantibodies, or thymoma. We present three new patients with electrically-silent muscle rippling and abnormal caveolin-3 localisation, but without acetylcholine receptor autoantibodies, or clinical or electrophysiological evidence of myasthenia gravis. An autoimmune basis for rippling muscle disease is supported by spontaneous recovery and normalisation of caveolin-3 staining in one patient and alleviation of symptoms in response to plasmapheresis and immunosuppression in another. These patients expand the autoimmune rippling muscle disease phenotype, and suggest that autoantibodies to additional unidentified muscle proteins result in autoimmune rippling muscle disease. (C) 2010 Elsevier B.V. All rights reserved.


Publication metadata

Author(s): Lo HP, Bertini E, Mirabella M, Domazetovska A, Dale RC, Petrini S, D'Amico A, Valente EM, Barresi R, Roberts M, Tozzi G, Tasca G, Cooper ST, Straub V, North KN

Publication type: Article

Publication status: Published

Journal: Neuromuscular Disorders

Year: 2011

Volume: 21

Issue: 3

Pages: 194-203

Print publication date: 01/03/2011

ISSN (print): 0960-8966

ISSN (electronic): 1873-2364

Publisher: Elsevier

URL: http://dx.doi.org/10.1016/j.nmd.2010.11.015

DOI: 10.1016/j.nmd.2010.11.015


Altmetrics

Altmetrics provided by Altmetric


Funding

Funder referenceFunder name
NHS National Commissioning Group
Italian Ministry of Health
206527Australian National Health and Medical Research Council
301946Australian National Health and Medical Research Council
403941Australian National Health and Medical Research Council
ISTRIPQA1TREAT-NMD

Share